These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35896321)

  • 1. Cancer survivors and neurotoxic chemotherapy: hearing loss and tinnitus.
    Cheung S; Henderson-Sabes J; Mastick J; Abrams G; Snowberg K; Alfaro E; Quinn M; Paul S; Cooper B; Wallhagen M; Conley Y; Levine J; Miaskowski C
    BMJ Support Palliat Care; 2023 Sep; 13(3):345-353. PubMed ID: 35896321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations Between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors.
    Miaskowski C; Paul SM; Mastick J; Abrams G; Topp K; Smoot B; Kober KM; Chesney M; Mazor M; Mausisa G; Schumacher M; Conley YP; Sabes JH; Cheung S; Wallhagen M; Levine JD
    J Pain Symptom Manage; 2018 Jul; 56(1):88-97. PubMed ID: 29524582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life.
    Miaskowski C; Mastick J; Paul SM; Abrams G; Cheung S; Sabes JH; Kober KM; Schumacher M; Conley YP; Topp K; Smoot B; Mausisa G; Mazor M; Wallhagen M; Levine JD
    J Cancer Surviv; 2018 Apr; 12(2):234-245. PubMed ID: 29159795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.
    Miaskowski C; Paul SM; Mastick J; Schumacher M; Conley YP; Smoot B; Abrams G; Kober KM; Cheung S; Henderson-Sabes J; Chesney M; Mazor M; Wallhagen M; Levine JD
    Eur J Oncol Nurs; 2018 Feb; 32():1-11. PubMed ID: 29353626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
    Sanchez VA; Dinh PC; Rooker J; Monahan PO; Althouse SK; Fung C; Sesso HD; Einhorn LH; Dolan ME; Frisina RD; Travis LB
    J Cancer Surviv; 2023 Feb; 17(1):27-39. PubMed ID: 36637632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
    Brydøy M; Oldenburg J; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Hauge ER; Dahl O; Fosså SD
    J Natl Cancer Inst; 2009 Dec; 101(24):1682-95. PubMed ID: 19940282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study.
    Haugnes HS; Stenklev NC; Brydøy M; Dahl O; Wilsgaard T; Laukli E; Fosså SD
    Acta Oncol; 2018 Aug; 57(8):1075-1083. PubMed ID: 29384420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.
    Trendowski MR; Baedke JL; Sapkota Y; Travis LB; Zhang X; El Charif O; Wheeler HE; Leisenring WM; Robison LL; Hudson MM; Morton LM; Oeffinger KC; Howell RM; Armstrong GT; Bhatia S; Dolan ME
    Cancer; 2021 Nov; 127(21):4091-4102. PubMed ID: 34286861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.
    Phillips OR; Baguley DM; Pearson SE; Akeroyd MA
    J Cancer Surviv; 2023 Feb; 17(1):40-58. PubMed ID: 36637633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
    Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
    Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing screening and amplifier uptake results in a multidisciplinary head and neck cancer survivorship clinic.
    Zitelli L; Palmer C; Mamula E; Johnson J; Rauterkus G; Nilsen ML
    J Cancer Surviv; 2023 Jun; 17(3):720-728. PubMed ID: 35348995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective and Objective Hearing Loss Among US Adult Cancer Survivors.
    Wang Q; Jiang C; Wen C; Xie H; Li Y; Zhang Y; Mady LJ; Bruno DS; Dutcher GMA; Chiec LS; Dowlati A; Hsu ML
    JAMA Otolaryngol Head Neck Surg; 2023 Dec; 149(12):1101-1110. PubMed ID: 37796484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported hearing problems among older adults: prevalence and comparison to measured hearing impairment.
    Hannula S; Bloigu R; Majamaa K; Sorri M; Mäki-Torkko E
    J Am Acad Audiol; 2011 Sep; 22(8):550-9. PubMed ID: 22031679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments.
    Ardeshirrouhanifard S; Fossa SD; Huddart R; Monahan PO; Fung C; Song Y; Dolan ME; Feldman DR; Hamilton RJ; Vaughn D; Martin NE; Kollmannsberger C; Dinh P; Einhorn L; Frisina RD; Travis LB
    Ear Hear; 2022; 43(3):794-807. PubMed ID: 35067571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with cisplatin-induced ototoxicity in Japanese patients with solid tumors.
    Okada H; Kitagawa K
    Cancer Med; 2023 Apr; 12(7):7904-7910. PubMed ID: 36567514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audiometric thresholds among a Canadian sample of 10 to 17 year old students.
    Marcoux AM; Feder K; Keith SE; Marro L; James ME; Michaud DS
    J Acoust Soc Am; 2012 Apr; 131(4):2787-98. PubMed ID: 22501057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study.
    Pearson SE; Caimino C; Shabbir M; Baguley DM
    J Cancer Surviv; 2022 Oct; 16(5):976-987. PubMed ID: 34398361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review.
    Pearson SE; Taylor J; Patel P; Baguley DM
    Int J Audiol; 2019 Nov; 58(11):685-695. PubMed ID: 31545660
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of organic solvents and occupational noise on hearing loss and tinnitus among adults in the U.S., 1999-2004.
    Staudt AM; Whitworth KW; Chien LC; Whitehead LW; Gimeno Ruiz de Porras D
    Int Arch Occup Environ Health; 2019 Apr; 92(3):403-413. PubMed ID: 30806784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.
    Zhang X; Trendowski MR; Wilkinson E; Shahbazi M; Dinh PC; Shuey MM; ; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Huddart R; Martin NE; Sanchez VA; Frisina RD; Einhorn LH; Cox NJ; Travis LB; Dolan ME
    Cancer Med; 2022 Jul; 11(14):2801-2816. PubMed ID: 35322580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.